• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

45.49 -1.53 (-3.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 835,501
Open 47.00
Bid (Size) 45.50 (200)
Ask (Size) 47.00 (300)
Prev. Close 47.02
Today's Range 45.06 - 47.30
52wk Range 15.80 - 94.90
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Ways to Invest in the Growing GLP-1 Weight Loss Market ↗
April 17, 2026
Via MarketBeat
News headline image
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
April 14, 2026
From Structure Therapeutics Inc.
Via GlobeNewswire

Performance

YTD
-33.2%
-33.2%
1 Month
-5.5%
-5.5%
3 Month
-49.7%
-49.7%
6 Month
+72.4%
+72.4%
1 Year
+92.3%
+92.3%

More News

Read More
News headline image
The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
April 03, 2026
Via MarketMinute
Topics Intellectual Property
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗
January 14, 2026
Via Stocktwits
News headline image
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
April 02, 2026
Via MarketMinute
Topics Economy
News headline image
Main Street’s Revenge: The Great Rotation of 2026 Rewrites Market History
March 26, 2026
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
The Great Rotation: Small-Caps Seize Market Leadership in Historic 2026 Breakout
March 25, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Great Rotation: Russell 2000 Outshines Mega-Caps as Domestic Small-Caps Take the Reins in 2026
March 24, 2026
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges ↗
March 22, 2026
Via The Motley Fool
News headline image
3 Companies at the Forefront of the GLP-1 Pill Wars ↗
March 16, 2026
Via MarketBeat
News headline image
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
March 16, 2026
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗
February 27, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
February 27, 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
February 26, 2026
From Structure Therapeutics Inc.
Via GlobeNewswire
News headline image
Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗
February 25, 2026
Via The Motley Fool
News headline image
Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗
February 25, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗
February 25, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
February 17, 2026
Via MarketMinute
Topics Earnings Economy
News headline image
Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
February 17, 2026
Via The Motley Fool
News headline image
Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
February 06, 2026
Via MarketMinute
Topics Earnings Economy
News headline image
This Healthcare Company Believes Its GLP-1 Pill Could Be "Next in Line" After Novo Nordisk and Eli Lilly. Its Valuation Is a Fraction of Theirs. ↗
February 05, 2026
Via The Motley Fool
News headline image
A 10% Owner Of Structure Therapeutics Shed Shares ↗
January 13, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Can This Stock Double Again in 2026? ↗
January 11, 2026
Via The Motley Fool
News headline image
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗
January 05, 2026
Via Stocktwits

Frequently Asked Questions

Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?
Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.
What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?
Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?
The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market
What is the current price of Structure Therapeutics Inc. - American Depositary Shares?
The current price of Structure Therapeutics Inc. - American Depositary Shares is 45.49
When was Structure Therapeutics Inc. - American Depositary Shares last traded?
The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 04/24/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap